![Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine](https://www.who.int/images/default-source/departments/immunization-ivb/publications/sinopharm-vaccine-explainer-cover.tmb-479v.jpg?sfvrsn=28d56566_1 "Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine")
Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine
High-Density Vero Cell Perfusion Culture
Role of Cell Culture Technology in new Vaccine Development
Untitled
Vero Cell Cultivation for Vaccine Production
Vaccines | Free Full-Text | Development and Evaluation of Vero Cell-Derived Master Donor Viruses for Influenza Pandemic Preparedness | HTML
Rabies vaccine purification using HPLC, Estimation of residual vero cellular DNA by RT-PCR and potency analysis | Madridge Publishers
Vaccine Preparedness — Are We Ready for the Next Influenza Pandemic? | NEJM
GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles - ScienceDirect
Enhancing viral vaccine production using engineered knockout vero cell lines – A second look - ScienceDirect
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2 - ScienceDirect
Development of an inactivated vaccine candidate for SARS-CoV-2 | Science
Enhancing virus production using knockout Vero cell lines
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates | npj Vaccines
Vaccines | Free Full-Text | Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures
Optimizing Virus Production Media for Cell-based Vaccine manufacturing
Vaccines | Free Full-Text | Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development | HTML
DDA: EUA of covid 19 vaccine (Vero cell), inactivated manufactured by BIBP(under sinopharm)
Chinese Citizens Are Already Receiving a Coronavirus Vaccine | The New Yorker
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial - The Lancet
Impact Of A Chemically Defined Medium For Vero Cells Cultivation And Virus Production For Vaccine Applications
Development of improved vaccine cell lines against rotavirus | Scientific Data
A cell-based backup to speed up pandemic influenza vaccine production: Trends in Microbiology
A whole virion vaccine for COVID-19 produced via a novel inactivation method: results from animal challenge model studies | bioRxiv
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial - The Lancet
